TRVI position history
The shares of Trevi Therapeutics (TRVI) that VIKING GLOBAL INVESTORS LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q3: 4,400,000 shares, $6.8M, 0.03% of portfolio, New
- 2022 Q4: 4,400,000 shares, $8.5M, 0.04% of portfolio
- 2023 Q1: 4,400,000 shares, $8.1M, 0.04% of portfolio
- 2023 Q2: 4,400,000 shares, $11M, 0.04% of portfolio
- 2023 Q3: 4,400,000 shares, $9.6M, 0.04% of portfolio
- 2023 Q4: 4,400,000 shares, $5.9M, 0.02% of portfolio
- 2024 Q1: 4,400,000 shares, $15M, 0.06% of portfolio
- 2024 Q2: 4,400,000 shares, $13M, 0.05% of portfolio
- 2024 Q3: 4,400,000 shares, $15M, 0.05% of portfolio
- 2024 Q4: 4,400,000 shares, $18M, 0.06% of portfolio
- 2025 Q1: 3,227,792 shares, $20M, 0.06% of portfolio, Reduce −26.6%
- 2025 Q2: 1,543,000 shares, $8.4M, 0.02% of portfolio, Reduce −52.2%
- 2025 Q3: 5,128,875 shares, $47M, 0.12% of portfolio, Add +232.4%
- 2025 Q4: 3,198,644 shares, $40M, 0.11% of portfolio, Reduce −37.6%
- 2026 Q1: 3,198,644 shares, $38M, 0.11% of portfolio
- 2026 Q2: 1,544,644 shares, $29M, 0.08% of portfolio, Reduce −51.7%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|